Literature DB >> 2175344

Mutation in gelsolin gene in Finnish hereditary amyloidosis.

E Levy1, M Haltia, I Fernandez-Madrid, O Koivunen, J Ghiso, F Prelli, B Frangione.   

Abstract

Familial amyloidosis, Finnish type (FAF), is an autosomal dominant form of familial amyloid polyneuropathy. The novel amyloid fibril protein found in these patients is a degradation fragment of gelsolin, an actin-binding protein. We found a mutation (adenine for guanine) at nucleotide 654 of the gelsolin gene in genomic DNA isolated from five FAF patients. This site is polymorphic since the normal allele was also present in all the patients tested. This mutation was not found in two unaffected family members and 11 normal controls. The A for G transition causes an amino acid substitution (asparagine for aspartic acid) that was found at position 15 of the amyloid protein. The mutation and consequent amino acid substitution may lead to the development of FAF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175344      PMCID: PMC2188742          DOI: 10.1084/jem.172.6.1865

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy.

Authors:  G Boysen; G Galassi; Z Kamieniecka; J Schlaeger; W Trojaborg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-11       Impact factor: 10.154

2.  Expression of a normal and variant Alzheimer's beta-protein gene in amyloid of hereditary cerebral hemorrhage, Dutch type: DNA and protein diagnostic assays.

Authors:  F Prelli; E Levy; S G van Duinen; G T Bots; W Luyendijk; B Frangione
Journal:  Biochem Biophys Res Commun       Date:  1990-07-16       Impact factor: 3.575

3.  Genetic aspects of familial amyloidosis with corneal lattice dystrophy and cranial neuropathy.

Authors:  J Meretoja
Journal:  Clin Genet       Date:  1973       Impact factor: 4.438

4.  Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome.

Authors:  J Meretoja
Journal:  Ann Clin Res       Date:  1969-12

5.  Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy.

Authors:  B T Darras; L S Adelman; J S Mora; R A Bodziner; T L Munsat
Journal:  Neurology       Date:  1986-03       Impact factor: 9.910

6.  Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing.

Authors:  F Sanger; A R Coulson; B G Barrell; A J Smith; B A Roe
Journal:  J Mol Biol       Date:  1980-10-25       Impact factor: 5.469

7.  Three forms of dominant amyloid neuropathy.

Authors:  G H Sack; K W Dumars; K S Gummerson; A Law; V A McKusick
Journal:  Johns Hopkins Med J       Date:  1981-12

8.  Primary structure of an amyloid prealbumin and its plasma precursor in a heredofamilial polyneuropathy of Swedish origin.

Authors:  F E Dwulet; M D Benson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

9.  Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain.

Authors:  D J Kwiatkowski; T P Stossel; S H Orkin; J E Mole; H R Colten; H L Yin
Journal:  Nature       Date:  1986 Oct 2-8       Impact factor: 49.962

10.  Lattice corneal dystrophy associated with familial systemic amyloidosis (Meretoja's syndrome).

Authors:  J J Purcell; M Rodrigues; M I Chishti; R N Riner; J M Dooley
Journal:  Ophthalmology       Date:  1983-12       Impact factor: 12.079

View more
  39 in total

1.  Ophthaproblem. Lattice corneal dystrophy.

Authors:  J Cheung; S Sharma
Journal:  Can Fam Physician       Date:  2001-02       Impact factor: 3.275

Review 2.  Genetic animal models of cerebral vasculopathies.

Authors:  Jeong Hyun Lee; Brian J Bacskai; Cenk Ayata
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

3.  Metalloendoprotease cleavage triggers gelsolin amyloidogenesis.

Authors:  Lesley J Page; Ji Young Suk; Mary E Huff; Hee-Jong Lim; John Venable; John Yates; Jeffery W Kelly; William E Balch
Journal:  EMBO J       Date:  2005-11-10       Impact factor: 11.598

4.  Gene mutations in inherited amyloidopathies of the nervous system.

Authors:  R E Tanzi
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

Review 5.  Disorder-to-order conformational transitions in protein structure and its relationship to disease.

Authors:  Paola Mendoza-Espinosa; Victor García-González; Abel Moreno; Rolando Castillo; Jaime Mas-Oliva
Journal:  Mol Cell Biochem       Date:  2009-04-09       Impact factor: 3.396

6.  Clinical features and haplotype analysis of newly identified Japanese patients with gelsolin-related familial amyloidosis of Finnish type.

Authors:  Makiko Taira; Hiroyuki Ishiura; Jun Mitsui; Yuji Takahashi; Toshihiro Hayashi; Jun Shimizu; Takashi Matsukawa; Naoko Saito; Kazumasa Okada; Sadatoshi Tsuji; Hiromasa Sawamura; Shiro Amano; Jun Goto; Shoji Tsuji
Journal:  Neurogenetics       Date:  2012-05-24       Impact factor: 2.660

7.  Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with apoAI Leu178His amyloidosis.

Authors:  M M de Sousa; C Vital; D Ostler; R Fernandes; J Pouget-Abadie; D Carles; M J Saraiva
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

8.  The 8 and 5 kDa fragments of plasma gelsolin form amyloid fibrils by a nucleated polymerization mechanism, while the 68 kDa fragment is not amyloidogenic.

Authors:  James P Solomon; Isaac T Yonemoto; Amber N Murray; Joshua L Price; Evan T Powers; William E Balch; Jeffery W Kelly
Journal:  Biochemistry       Date:  2009-12-08       Impact factor: 3.162

Review 9.  Vascular Cognitive Impairment.

Authors:  Jonathan Graff-Radford
Journal:  Continuum (Minneap Minn)       Date:  2019-02

10.  Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro.

Authors:  F Tagliavini; F Prelli; L Verga; G Giaccone; R Sarma; P Gorevic; B Ghetti; F Passerini; E Ghibaudi; G Forloni
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.